SVA Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$1.88M Sell
32,341
-6,506
-17% -$393K 0.16% 101
2020
Q3
$2.46M Sell
38,847
-3,307
-8% -$229K 0.24% 82
2020
Q2
$3.24M Buy
42,154
+2,900
+7% +$222K 0.35% 62
2020
Q1
$2.94M Buy
39,254
+5,382
+16% +$372K 0.34% 56
2019
Q4
$2.2M Sell
33,872
-74
-0.2% -$4.82K 0.2% 92
2019
Q3
$2.15M Buy
33,946
+493
+1% +$32.2K 0.21% 91
2019
Q2
$2.26M Sell
33,453
-399
-1% -$26.2K 0.22% 87
2019
Q1
$2.2M Buy
33,852
+5,801
+21% +$386K 0.21% 92
2018
Q4
$1.75M Sell
28,051
-4,990
-15% -$349K 0.2% 94
2018
Q3
$2.55M Buy
+33,041
New +$2.5M 0.26% 80
2018
Q2
Sell
-2,720
Closed -$220K 219
2018
Q1
$220K Buy
+2,720
New +$216K 0.03% 195
2017
Q4
Sell
-2,720
Closed -$220K 206
2017
Q3
$220K Buy
+2,720
New +$208K 0.03% 195
2017
Q2
Sell
-2,970
Closed -$202K 201
2017
Q1
$202K Sell
2,970
-388
-12% -$27.3K 0.03% 190
2016
Q4
$240K Sell
3,358
-58
-2% -$4.31K 0.04% 182
2016
Q3
$270K Buy
3,416
+557
+19% +$45.2K 0.04% 170
2016
Q2
$238K Hold
2,859
0.04% 179
2016
Q1
$263K Buy
2,859
+172
+6% +$15.5K 0.04% 175
2015
Q4
$272K Buy
+2,687
New +$280K 0.05% 188

Other funds holding GILD

SVA Wealth Management's GILD Position: Q4 2020 in Review

SVA Wealth Management reduced its Gilead Sciences (GILD) stake by 17% in Q4 2020, selling an estimated $393K and leaving 32,341 shares worth $1.88M. The position accounts for 0.16% of the portfolio, ranked #101.

SVA Wealth Management first reported a position in GILD in Q4 2015 and has held it in 18 quarters since. The position peaked at $3.24M in Q2 2020. 1,563 funds tracked by Wall St. Rank hold GILD as of Q4 2020.

  • SVA Wealth Management held 32,341 shares of Gilead Sciences worth $1.88M as of Q4 2020.
  • SVA Wealth Management sold 6,506 Gilead Sciences shares in Q4 2020, an estimated $393K.
  • Gilead Sciences made up 0.16% of SVA Wealth Management's portfolio in Q4 2020, its #101 holding.
  • SVA Wealth Management first reported a position in Gilead Sciences in Q4 2015 and has held it in 18 quarters since.
  • SVA Wealth Management's Gilead Sciences position peaked at $3.24M in Q2 2020.
  • 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.

Based on SVA Wealth Management's 13F filing for Q4 2020, filed 4 Feb 2021.